Delivery Order SPE2DB24D2205-SPE2DB25FEFEA
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,273.18 to AmerisourceBergen Drug Corp for Dexcom G6 Sensor 3-packs on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order represents a non-competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1...
- The Defense Logistics Agency awarded a $10,283.29 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 21, 2025, with an ultimate completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a $4,419.80 delivery order to AmerisourceBergen Drug Corp for Dexcom G6 Sensor 3S continuous glucose monitoring devices on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of the vendor's extensive role in supporting federal medical supply needs. The supplies will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors valued at $2,188.74. This firm fixed-price delivery order was competitively awarded without a set-aside designation and carries an ultimate completion date of July 22, 2025. The award represents a child contract under AmerisourceBergen's larger pharmaceutical supply framework with the federal government. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $9,922.90 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 21, 2025, with completion targeted for July 22, 2025. This non-set-aside contract employs firm fixed pricing and represents a direct fulfillment of medical supply needs through the company's existing indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $6,788.95 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 21, 2025, with completion targeted for July 22, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,062.40 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 21, 2025, with completion expected by July 22, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, particularly supporting military and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $39,478.48 to AmerisourceBergen Drug Corp for the supply of DEXCOM G6 SENSOR 3S medical devices. The contract has an ultimate completion date of September 11, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies to provide a wide range of pharmaceutical and medical products, including...
- The Defense Logistics Agency awarded a $1,832 delivery order to Amerisourcebergen Drug Corporation for Dexcom G6 sensors. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and calls for delivery of the medical devices to a facility in Conshohocken, Pennsylvania by July 3, 2023. As a leading supplier of medical and surgical goods to the Department of Defense, Amerisourcebergen will deliver the glucose monitoring sensors in support of DLA's mission to...
- The Defense Logistics Agency awarded a $1,261 delivery order to Amerisourcebergen Drug Corporation for Dexcom G6 sensors. The firm fixed price order is for a one day period of performance from July 5-6, 2023 in Conshohocken, Pennsylvania. As a major distributor of medical supplies to the Department of Defense, Amerisourcebergen will deliver the continuous glucose monitoring devices in support of DLA's provision of critical healthcare materials. No subcontractors or set aside designations were...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFEADelivery Order
The Defense Logistics Agency awarded a $1,304.80 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for Dexcom G6 Sensor 3S continuous glucose monitoring devices. This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania, and a completion deadline of July 22, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor with an extensive portfolio of competitively awarded contracts. The company supplies a comprehensive range of healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, including brand-name and generic medications, vaccines, medical devices, and specialized supplies. This award for continuous glucose monitoring sensors reflects the company's role in supporting military personnel and veterans' diabetes management and broader healthcare needs across the defense medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/21/25 |